MAPT and Alzheimer disease: Furthermore, the detection of total and phosphorylated Tau (p-Tau) in CSF samples has also been used to diagnose MCI and AD with at least 85% sensitivity and 80% specificity, indicating neuronal damage and predicting progression from MCI to AD [35].